logologo
Search anything
Ctrl+K
arrow
WhatsApp Icon

Zydus Wellness Q3 FY26: Strategic Acquisitions Drive Robust Growth Amidst Market Shifts

ZYDUSWELL

Zydus Wellness Ltd

ZYDUSWELL

Ask AI

Ask AI

Zydus Wellness Limited, a prominent player in the consumer wellness sector, reported a robust consolidated net sales growth of 113.7% for the third quarter of fiscal year 2026, reaching INR 963.3 crore. This significant surge was primarily fueled by the strong performance of its newly acquired businesses. The company's EBITDA also saw a remarkable increase of 312.2% year-on-year, touching INR 61 crore, with the EBITDA margin expanding to 6.3% from 3.2% in the previous year. While the Food & Nutrition segment delivered an impressive 134% growth, the Personal Care segment experienced a slight decline of 1.4% during the quarter. Despite reporting a net loss, largely due to acquisition-related expenses, the underlying operational momentum and strategic expansions highlight a transformative period for Zydus Wellness.

Segmental Performance and Strategic Plays

The Food & Nutrition segment's exceptional growth was a direct result of the successful integration and performance of recent acquisitions. The Comfort Click business, for instance, continued to perform in line with expectations, deepening its portfolio with new adult gummies variants, probiotic gummies for kids, and Pure Himalayan Shilajit Resin. This move reinforces its presence in high-growth wellness categories. Furthermore, the WeightWorld brand, part of Comfort Click, expanded its European footprint by entering Poland, Finland, and Portugal, strengthening its regional market access. These strategic expansions are crucial for unlocking fast-growing wellness markets across Europe.

RiteBite Max Protein, another key acquisition, significantly outperformed internal projections, doubling its legacy performance. The brand expanded its international presence to nine countries within its first year and launched a new Wafer Bar in India, contributing to category growth. Nutralite Professional also broadened its offerings with Cheesy Delight and Slim Mayonnaise variants, enhancing its portfolio and driving incremental growth in food service channels. These initiatives underscore Zydus Wellness's commitment to innovation and market penetration across diverse product categories.

Financial Metric (INR Crore)Q3 FY26Q3 FY25YoY Growth %
Net Sales963.3450.8113.7%
Revenue from Operation964.9461.9108.9%
Gross Contribution611.8226.3170.3%
EBITDA61.014.8312.2%
PBT(34.9)10.1-445.5%
PAT(39.9)6.4-723.4%

While the growth narrative is strong, Zydus Wellness faced certain headwinds. The Personal Care segment's slight decline was attributed to unfavorable weather conditions that tempered category demand for seasonal brands like Glucon-D and Nycil. Brand saliency for these products was also limited during the quarter due to seasonal factors. Additionally, the company reported a net loss for the quarter, primarily driven by significant finance costs of INR 37.1 crore (due to a low-cost bridge loan for acquisitions) and high depreciation and amortization expenses of INR 47.2 crore resulting from acquired brands. The decline in other operating income, due to a one-time GST budgetary support recognized in the prior year, also impacted year-on-year comparisons.

Despite these challenges, management remains optimistic about the future. They highlighted that Comfort Click's acquisition is cash EPS accretive, even after accounting for interest and tax. Gross margins expanded across most brands, underscoring the strength of the portfolio. The company is actively working on improving segmental disclosures to provide better visibility to investors. Furthermore, Zydus Wellness plans to reframe Complan's participation in the nutrition space with relaunches and new product introductions, alongside expanding celebrity-led outreach to connect with younger audiences.

Strategic Vision and Investor Confidence

Zydus Wellness is strategically positioned for sustained growth, leveraging its strong brand equity and expanding global footprint. The management's guidance indicates continued double-digit top-line growth for Comfort Click, with EBITDA margins expected to be above 14%. The base business is also projected to achieve EBITDA margins of 16-18% in the next one to two years. The Max Protein business is anticipated to reach an aspirational revenue scale of INR 500 crore within two years. The company's commitment to talent development and workplace excellence, evidenced by its certification as a 'Great Place to Work' for four consecutive years, further strengthens investor confidence.

Zydus Wellness's Q3 FY26 performance reflects a company in a dynamic growth phase, strategically integrating acquisitions and expanding its market reach. While short-term profitability was impacted by acquisition-related costs, the underlying operational strength and clear strategic direction position the company for long-term value creation in the evolving consumer wellness landscape.

Frequently Asked Questions

Zydus Wellness reported a consolidated net sales growth of 113.7% to INR 963.3 crore and an EBITDA growth of 312.2% to INR 61 crore for Q3 FY26. However, the company recorded a net loss of INR 39.9 crore for the quarter.
The Food & Nutrition segment delivered a strong growth of 134% in Q3 FY26. In contrast, the Personal Care segment experienced a slight decline of 1.4% during the same period.
Recent acquisitions significantly contributed to growth. RiteBite Max Protein doubled its legacy performance and exceeded internal projections, while Comfort Click performed as expected and is cash EPS accretive. These acquisitions also led to higher interest and amortization expenses impacting net profitability.
Zydus Wellness launched new gummies and Pure Himalayan Shilajit Resin under Comfort Click. The WeightWorld brand expanded into Poland, Finland, and Portugal. Nutralite Professional introduced Cheesy Delight and Slim Mayonnaise variants, and RiteBite Max Protein launched a Wafer Bar in India.
Management expects Comfort Click to achieve double-digit top-line growth with over 14% EBITDA margins. The base business aims for 16-18% EBITDA margins in the next 1-2 years, and the Max Protein business has the potential to reach INR 500 crore revenue in two years. The company also expects EPS accretion at the PAT level for the newly acquired entity from the next financial year.
Challenges included tempered demand for seasonal brands like Glucon-D and Nycil due to unfavorable weather, a decline in other operating income due to a prior-year one-time benefit, and increased finance and amortization costs from acquisitions impacting net profitability.
Management acknowledged that current segmental disclosures could be more granular and stated that they would work on providing better visibility and improved disclosures by the end of the year.

A NOTE FROM THE FOUNDER

Hey, I'm Aaditya, founder of Multibagg AI. If you enjoyed reading this article, you've only seen a small part of what's possible with Multibagg AI. Here's what you can do next:

It's all about thinking better as an investor. Welcome to a smarter way of doing stock market research.